Raymond Runyan, PhD

Professor, Cellular and Molecular Medicine
Research Scientist, Sarver Heart Center
Investigator, Center for Toxicology
Professor, Physiological Sciences - GIDP
Major Areas of Research Interest: 

In the heart, cells that form the valves are induced to develop by interaction between endothelial cells and adjacent muscle. As a result, cardiac endothelial cells transform into mesenchyme and become the constituents of the valves and walls of the heart. This process is known as an epithelial-mesenchymal transition or EMT. The objective of my research program is to understand the molecular mechanisms that mediate cell transformation in the heart.

Using a tissue culture assay, we showed that cardiac endothelia would only transform after stimulation by adjacent muscle. My laboratory has continued to examine the events which take place during this epithelial-mesenchymal cell transformation. Our studies focus upon three basic questions. 1) What is the nature of the signal produced by the muscle? 2) How do the target cells recognize the signal? 3) What events occur in the target cells in response to the stimulus? Answers to these questions will identify potential causes of congenital heart defects.

Work in the laboratory initially focused on the observation that the growth factor, Transforming Growth Factor Beta, is a component of the transformation process. As this growth factor is actually a member of a family of related molecules, we used RNase protection assays to show that two isoforms, TGFbeta2 and TGFbeta3, were found in the heart. Experiments using antisense DNA oligonucleotides demonstrated that TGFbeta3 is the critical component. More recently, our work shows that both isoforms are used in complementary roles.

Experiments show that this EMT in the heart is blocked by loss of several different classes of TGFbeta receptors, including Alk2, Alk5, TGFbetaType II, TGFbetaType III and Endoglin. As seen with the two different TGFbeta isoforms, each receptor component appears to mediate play a distinct role in the EMT process. Other experiments in this laboratory showed that EMT is sensitive to inhibitors of several classes of kinases, Gi proteins, and the phosphoinositide pathway. These pathways are being explored by cloning and targeted degradation of mRNAs of various components in order to track signals from the cell surface to the nucleus.

Another approach to the problem is towards the identification of regulatory genes expressed in response to the cardiac signal. Our focus is the immediate early genes which are likely to be transcriptional regulators of other genes required for valve formation. Our most recent efforts have focused on the genes Slug (Snail2), Meox-1, Runx2 and Paraxis. All of these genes appear to be critical transcription factors for the process of cell transformation.

A related research program in the lab is focused upon examining the relationship between events which take place during early valve development and the apparent cardio-teratogenicity of the environmental contaminant Trichloroethylene (TCE). In association with members of the Southwestern Environmental Health Sciences Center and the Superfund Program here at Arizona, we are trying to identify genes that are altered in developing hearts by exposure to this chemical.

Selected Publications: 

Lencinas A, Broka DM, Konieczka JH, Klewer SE, Antin PB, Camenisch TD, Runyan RB. Mar 2010. Arsenic Exposure Perturbs Epithelial-Mesenchymal Cell Transition (EMT) and Gene Expression In a Collagen Gel Assay. Toxicol Sci,

Caldwell PT, Manziello A, Howard J, Palbykin B, Runyan RB, Selmin O. Feb 2010. Gene expression profiling in the fetal cardiac tissue after folate and low-dose trichloroethylene exposure. Birth Defects Res A Clin Mol Teratol, 88:111-27

Makwana O, King NM, Ahles L, Selmin O, Granzier HL, Runyan RB. Jun 2010. Exposure to low-dose trichloroethylene alters shear stress gene expression and function in the developing chick heart. Cardiovasc Toxicol, 10:100-7

Rausch MP, Hahn T, Ramanathapuram L, Bradley-Dunlop D, Mahadevan D, Mercado-Pimentel ME, Runyan RB, Besselsen DG, Zhang X, Cheung HK, Lee WC, Ling LE, Akporiaye ET. Jun 2009. An orally active small molecule TGF-beta receptor I antagonist inhibits the growth of metastatic murine breast cancer. Anticancer Res, 29:2099-109

Sponsored Research Through MSRP: 

Tijana Milinic, (MSRP 2015); "Stem Cells & Extracellular Matrix Therapy in Infarcted Porcine Heart"

Alejandro Lencinas, (MSRP 2015, 2016, 2017); "Myocardial Cell Function Improvement Via Mitochondrial Transfer After a Myocardial Infarction"

NIH Undergraduate Diversity Program: 
Tricia Hindley, 2011, "Ofactomedin (Noelin-1) a Known Marker in Gliobastoma"
Elizabeth A. Hoover, "2011ALH1a1 in Embryonic Heart Development"
Abeer Lafta, 2012, "Magnetic targeting of cell invasion  (EMT)"; 2014, "Unidirectional Mitochondria Transfer from Human Stem Cells to Cardio-Myocytes"; 2015, "Olfactomedin Variants 1&3 have differential effects on Epithelial-Mesenchmal Transition in the chick embryonic heart"; 2016, "Olfactomedin have differential effects during the process of EMT on chick embryonic heart"
Tony Thao, 2012, "Regulation of Olfactomedin-1 as a Mediator of Epithelial-Mesenchymal Transition"
NIH High School Student Research Program: 
-Tricia Hindley, Pueblo Magnet High School, 2011
-Abeer Lafta, Palo Verde High School, 2012
-Danielle Brown, Valley High School, 2013
-Ashley Meder, Rio Rico High School, 2013
-Cecilia Machado, Pueblo High School, 2014
-Karla Mendez, Trevor Browne High School, 2015
-Edgardo Felix, Trevor Browne High School, 2016
-Sapphira Tsinnijinnie, Shonto Prep Tech High School, 2017
Wednesday, March 7, 2018